B
BrainDTech utilizes patented methods for the early detection and monitoring of neurological and neurodegenerative diseases through the analysis of miRNA signatures in microglial microvesicles obtained from liquid biopsies. This technology enables the identification of disease-specific biomarkers before clinical symptoms arise, facilitating timely intervention and treatment evaluation.
Updated 4 months ago
Funding
$3.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- BrainDTech utilizes patented methods for the early detection and monitoring of neurological and neurodegenerative diseases through the analysis of miRNA signatures in microglial microvesicles obtained from liquid biopsies. This technology enables the identification of disease-specific biomarkers before clinical symptoms arise, facilitating timely intervention and treatment evaluation.